date:Jul 05, 2012
affected.
On the acquisition trail
Jandali would not be drawn on the criteria for making further acquisitions, beyond saying BASF remains open to doing deals with companies that have ingredients supported by science, and has the funds available shouldthe right opportunity present itself.
Meanwhile, its recent acquisition of high-end omega-3 producer Equateq shows BASF puts its money where its mouth is, adds Jandali, who says Equateqs proprietary chromatographic separation methods allow flexib